Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.

Item
http://www.wikidata.org/entity/Q34986035
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsRole for the nicotinic cholinergic system in movement disorders; therapeutic implications.Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats.Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations.Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats.Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias.Levodopa treatment and dendritic spine pathology.Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.
P2860

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.

Item
http://www.wikidata.org/entity/Q34986035
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@ast
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@en
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@nl
type
label
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@ast
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@en
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@nl
prefLabel
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@ast
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@en
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Modulating mGluR5 and 5-HT1A/1 ...... possible mechanisms of action
@en
P2093
P304
P31
P356
10.1016/J.EXPNEUROL.2013.09.003
P407
P478
P50
P577
P5875
P698
P921